Gilead Sciences, Inc. (GIS.F)
Develops medicines to treat HIV, hepatitis, cancer, and other serious diseases.
117.56-0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+20.3%
The outlook
Gilead Sciences is trading near recent highs, sitting about 63% of the way through its 52-week range and above both its 50- and 200-day moving averages. The stock carries a trailing P/E of 18.2 and shows analyst lean toward a bullish outlook. Current price sits near intraday flat.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range63% of the way from its 52-week low to high
Market cap
$145.96B
52-wk high
132.00
52-wk low
93.42
50-day avg
112.71
200-day avg
113.52
Trailing P/E
18.2